Giant cell tumors of the tendon sheath are described as firm, lobulated masses that may cause no symptoms or patients may present with impaired mobility of the affected segment with distal paresthesia. Pain is uncommon. Lesions usually have a slow progression rate, but faster growth (within weeks) has also been reported. They usually occur in the distal interphalangeal joints rather than larger articulations [1] [2], especially on their palmar or plantar side [3], near the extensor or flexor tendon sheath and may extend and implicate both volar and dorsal parts of the digits. Metastasis has not been described, but recurrence after excision may be as high as 44%. Clinical examination reveals the fact that they are solitary or multinodular masses, adherent to the underlying and overlying structures, or skin may be mobile over the lesion. The examiner should try to determine if the joint capsule, nerves or vessels are compressed by the tumor or if adjacent bone erosion is present. Ankles, elbows, wrists and knees may also be involved [4]. In children upper and lower extremities are equally affected [5], but the disease more often appears in 30 to 50 years old individuals, slightly more frequently in women. The right hand is more often affected. Transillumination is negative in giant cell tumors of the tendon sheath, making differential diagnosis with cysts easier.

Clinical examination must be followed by an imaging workup in order to establish the diagnosis of a giant cell tumor of the tendon sheath. The first step is to perform a plain radiography, that shows a well circumscribed, sometimes calcified tumor that may cause bone erosion [6] due to its pressure effect and, not due to direct invasion.

If radiological features are inconclusive then a magnetic resonance imaging scan should be performed. This examination will establish the soft tissue character of the pathological process [7] and may highlight decreased signal intensity in certain areas, due to hemosiderin accumulation.

Echography offers information about tumor size, internal vascularization- which is often rich, echogenity (hypo [8] or hyperechoic [9]), location and relationship with neighboring structures [10]. Due to the fact that tumors are usually superficial, they can be well characterized using this method. Tumor borders are usually clear.

If clinical presentation dictates excision, the diagnosis will also be confirmed by means of histology. Tumors are usually 0.5 to 5 cm in diameter and composed of rounded or polygonal cells, collagen, inflammatory cells histiocytes, giant cells and xanthoma cells, rich in hemosiderin [11] embedded in a fibrous matrix [12]. A fibrous capsule surrounds this. The tumor has low mitotic activity and necrosis is rarely seen. Mitotic activity is not a predictor for future recurrence.

The primary treatment for Tendon Sheath Giant Cell Tumor is surgical removal. The goal of surgery is to excise the tumor completely while preserving the function of the affected joint or tendon. In some cases, particularly when the tumor is large or involves critical structures, complete removal may be challenging, and additional treatments such as radiation therapy may be considered to reduce the risk of recurrence. Postoperative rehabilitation may be necessary to restore function and mobility.

The prognosis for patients with Tendon Sheath Giant Cell Tumor is generally favorable, as these tumors are benign and do not metastasize. However, they can be locally aggressive and have a tendency to recur, particularly if not completely excised. Recurrence rates vary, but they can be as high as 30-50% in some cases. Regular follow-up with imaging studies is recommended to monitor for recurrence.

The exact cause of Tendon Sheath Giant Cell Tumor is not well understood. It is believed to result from an abnormal proliferation of synovial cells, which are the cells that line the joints and tendons. Some researchers suggest that trauma or inflammation may play a role in the development of these tumors, but there is no definitive evidence to support this theory.

Tendon Sheath Giant Cell Tumor is a rare condition, with an estimated incidence of 1.8 cases per million people per year. It can occur at any age but is most commonly diagnosed in adults between the ages of 30 and 50. There is a slight female predominance. The tumor most frequently affects the fingers and hands, but it can also occur in other joints and tendons throughout the body.

The pathophysiology of Tendon Sheath Giant Cell Tumor involves the proliferation of synovial cells, leading to the formation of a mass. These tumors are characterized by the presence of multinucleated giant cells, hemosiderin deposits (a breakdown product of blood), and inflammatory cells. The exact mechanisms driving this proliferation are not fully understood, but genetic and molecular factors may play a role.

There are no known measures to prevent the development of Tendon Sheath Giant Cell Tumor, as the exact cause is not well understood. Early detection and treatment are important to prevent complications and reduce the risk of recurrence. Patients with a history of these tumors should have regular follow-up appointments to monitor for any signs of recurrence.

Tendon Sheath Giant Cell Tumor is a rare, benign tumor that affects the synovial lining of tendons and joints. It typically presents as a painless, slow-growing mass, most commonly in the fingers or hands. Diagnosis involves clinical examination, imaging studies, and biopsy. Treatment is primarily surgical, with a focus on complete excision to minimize the risk of recurrence. The prognosis is generally good, but regular follow-up is important due to the potential for recurrence.

If you have been diagnosed with a Tendon Sheath Giant Cell Tumor, it's important to understand that this is a benign condition, meaning it is not cancerous and does not spread to other parts of the body. Treatment usually involves surgery to remove the tumor, and most people recover well with minimal complications. However, there is a chance that the tumor could come back, so regular check-ups with your doctor are important. If you notice any new or recurring symptoms, such as swelling or pain near a joint or tendon, be sure to inform your healthcare provider.

1. Uriburu I, Levy V. Intraosseous growth of giant cell tumors of tendon sheath of the digits: report of 15 cases. J Hand Surg. 1998;23:732–736.
2. Garg B, Kotwal P. Giant cell tumour of the tendon sheath of the hand. J Orthop Surg. 2011;19(2):218-220.
3. Briët J, Becker S, Oosterhoff T, et al. Giant cell tumor of tendon sheath. Arch Bone Jt Surg. 2015;3(1):19-21.
4. Findling J, Lascola N, Groner T. Giant cell tumor of the flexor hallucis longus tendon sheath: a case study. J Am Podiatr Med Assoc. 2011;101(2):187-189.
5. Gholve P, Hosalkar H, Kreiger P, et al. Giant cell tumor of tendon sheath: largest single series in children. J Pediatr Orthop. 2007;27:67–74.
6. Karasick D, Karasick S. Giant cell tumor of tendon sheath: spectrum of radiologic findings. Skeletal Radiol. 1992;21:219–224.
7. Bancroft L, Peterson J, Kransdorf M. Imaging of soft tissue lesions of the foot and ankle. Radiol Clin North Am. 2008;46(6):1093-1103.
8. Ho C, Chiou H, Chou Y, et al. Peritendinous lesions: the role of high-resolution ultrasonography. Clin Imaging. 2003;27:239–250.
9. Peh W, Wong Y, Shek T, et al. Giant cell tumour of the tendon sheath of the hand: a pictorial essay. Australas Radiol. 2001;45:274–280.
10. Middleton W, Patel V, Teefey S, et al. Giant cell tumors of the tendon sheath: analysis of sonographic findings. AJR Am J Roentgenol 2004;183:337–339.
11. Iyer V, Kapila K, Verma K. Fine-needle aspiration cytology of giant cell tumor of tendon sheath. Diagn Cytopathol. 2003;29(2):105-110.
12. Ly J, Carlson C, Lagatta L, et al. Giant cell tumor of the peroneus tendon sheath. AJR Am J Roentgenol. 2003;180(5):1442.